Patent · US Active

Treatment of intrahepatic cholestatic diseases

US10813896B2 · kind B2 · utility

1Cited by
11References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2019
Grant dateOct 27, 2020
Priority date—
Expiry dateNov 6, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.